Seegene succeeds in developing reagents using AI for the first time

Published: 2018-01-04 16:27:00
Updated: 2018-01-04 14:31:49

Seegene succeeded in developing a molecular diagnosis reagent only in 4 days with its self-developed automated AI reagent development system.

Seegene(CEO Jong-Yoon Chun), a molecular diagnosis company, announced on the 3rd the company succeeded in developing a meningoencephalitis reagent and a h...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.